LMF
AVEO

LMR Master Fund’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

LMR Master Fund’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		$38K Buy
+2,063
New +$41.3K ﹤0.01% 338

Other funds holding AVEO

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LMR Master Fund's AVEO Position: Q4 2013 in Review

LMR Master Fund opened a new position in AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2013: 2,063 shares worth $38K. The stake represents ﹤0.01% of the portfolio and ranks #338 among its holdings.

70 funds tracked by Wall St. Rank hold AVEO as of Q4 2013.

  • LMR Master Fund held 2,063 shares of AVEO Pharmaceuticals, Inc. worth $38K as of Q4 2013.
  • AVEO Pharmaceuticals, Inc. was a new LMR Master Fund position in Q4 2013.
  • AVEO Pharmaceuticals, Inc. made up ﹤0.01% of LMR Master Fund's portfolio in Q4 2013, its #338 holding.
  • 70 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2013.

Based on LMR Master Fund's 13F filing for Q4 2013, filed 14 Feb 2014.